Stryker, Smith+Nephew, J&J, and more had orthopedic innovation announcements at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting in San Diego. There was also news about products, data and more at AAOS 2025 last week. [Want to find out more about the present state of the orthopedic device industry? Check out our MassDevice Orthopedic […]
Metal-on-Metal
Zimmer Biomet wins FDA nod for new total knee component
Zimmer Biomet (NYSE:ZBH) announced today that it received FDA 510(k) clearance for its Persona SoluTion porous plasma spray femur. The total knee implant component offers an alternative for patients with sensitivities to bone cement and/or metal. It features a porous coating for cementless fixation and leverages a proprietary surface treatment designed to enhance wear performance. […]
Smith+Nephew stock sinks as surgical business faces China headwinds
Smith+Nephew (NYSE:SNN) shares took a hit today on third-quarter results that highlighted ongoing struggles in China. Shares of SNN were down more than 12% to $25.35 apiece by the afternoon today. The London-based orthopedic giant is the latest medtech company to report issues in that region. GE HealthCare, Philips, Siemens Healthineers, BD and Intuitive also recently highlighted issues in the […]
Bioretec to increase production capacity for bioresorbable implants
Bioretec announced today that it acquired a new CNC machining center to increase the production capacity of its RemeOs products. Tampere, Finland-based Bioretec said its acquisition is optimized for the production of magnesium-based implants. This especially includes the first product from the RemeOs family, the RemeOs screw. Bioretec’s RemeOs screw received FDA approval in March. […]
FDA approves bioresorbable metal implant from Bioretec
Bioretec announced today that it received FDA marketing authorization for its RemeOs trauma screw, a bioresorbable metal implant. Tampere, Finland-based Bioretec says the screw is the first and only bioresorbable metal implant approved by the FDA. The product’s range and indication align with a clinical trial conducted in the ankle, according to a news release. […]
Zimmer Biomet loses appeal on $3.5M hip implant suit verdict
A U.S. Court of Appeals denied an appeal from Zimmer Biomet (NYSE:ZBH) to move to a new trial after a $3.5 million hip implant lawsuit verdict. In 2020, a federal jury in Iowa awarded $3.55 million to Lori Nicholson and her husband Willis for injuries sustained as a result of the company’s much-litigated M2a Magnum […]
Stryker leaders talk medtech trends at DeviceTalks Boston: ‘If you’re slow, you’re going to lose’
The first day of DeviceTalks Boston closed with a panel of Stryker (NYSE:SYK) executives discussing new tools, technologies and strategies in medtech. Digital VP Tracy Robertson, Digital, Robotics, and Enabling Technologies President Robert Cohen and Surgical Technologies VP of Digital Innovation Siddarth Satish offered their thoughts on industry trends in healthcare and at the Kalamazoo, […]
Zimmer Biomet slides on lowered 2021 guidance
Zimmer Biomet (NYSE:ZBH) shares took a hit today as it lowered its guidance despite its third-quarter results beating The Street. The Warsaw, Indiana-based company posted profits of $145.6 million, or 69¢ per share, on sales of more than $1.9 billion for the three months ended Sept. 30, 2021, for a 40% bottom-line slide on a […]
Corin Group picks head of Medtronic’s spine business as its CEO
Corin Group announced today that it appointed former Medtronic executive Jacob Paul as its new CEO. Cirencester, U.K.–based Corin Group said in a news release that Paul “brings unparalleled strategic and operational experience” to the company and is “well placed” to lead it through the next phase of its mission to improve patient activity and […]
FDA raises concerns about NuVasive Magec devices
The FDA today issued a notice warning patients, caregivers and healthcare providers of potential issues with Magec devices from NuVasive (NSDQ:NUVA). NuVasive’s Magec, a growing spinal rod system intended for use in children under 10, uses magnets to help correct spinal deformities as the child grows. The company designed Magec to help avoid multiple operations while […]
FDA warns of biocompatibility concerns with NuVasive’s Precise devices
The FDA today informed healthcare providers of potential biocompatibility concerns with Precice devices from NuVasive (NSDQ:NUVA). Precice devices are implants for those 18 years of age and older and are used to lengthen the limb, shorten or compress the limb or transport segments of long bones. They include adjustable rods that are placed inside a […]
